We're supporting science to bring innovative solutions to combat infectious disease in the most affected communities.
Our mission is to support science to bring innovative solutions to combat infectious disease in the most affected communities.
We maximise this impact through partnerships, advocacy and championing of evidence.
Antimicrobial resistance is one of our greatest public health threats. We need collective, evidence-based action to control the escalating burden of drug-resistant infections.
Funding research
We support the research and development of innovative solutions for combating infectious disease in the regions with the greatest burden. We focus on two important threats to infectious disease control:
- drug-resistant infections (including tuberculosis and fungal diseases)
- diseases impacted by environmental change (specifically, arboviruses, schistosomiasis, leishmaniasis and cholera)
Supporting equitable research
We’re ensuring research considers the needs and priorities of the most affected communities, so evidence and interventions are acceptable, affordable and accessible in the locations they are most needed.
Maximising impact
Through partnerships, advocacy and championing of evidence, we’re addressing barriers in the research and development ecosystem that delay innovations reaching patients.
Our Infectious Disease programme funds research to improve understanding and advance interventions to control and combat infectious diseases. You may also be interested in our Discovery Research programme which funds fields and disciplines seeking new knowledge on life, health and wellbeing, including all aspects of infectious disease.